Autopsy report · NCT03975101

Very Small Embryonic-like Stem Cells for Knee Osteoarthritis

“Policy changes have contributed to the failure to carry out smoothly”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Fuda Cancer Hospital, Guangzhou

Sponsor type

University, hospital or other

Conditions

Stem Cell Transplant Complications; Knee Osteoarthritis

Interventions

very small embryonic-like stem cell

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Improving End-of-life Care by Continuing Medical Education and Electronic Decision Making Support for General Practitioners
  “due to organisational changes” (58% match in meaning)
• TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia
  “Change in institutional policy. Change in resources available.” (57% match in meaning)
• Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients
  “Changes in country regulation” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.